These findings follow previously announced positive top-line results from two other global Phase 3 clinical studies, OBERON (NCT05166889) and TITANIA (NCT05158387), showing that tozorakimab at a ...
Tozorakimab, an investigational monoclonal antibody targeting the IL-33 pathway, significantly reduced moderate-to-severe ...
10d
More than 140,000 Americans die from COPD each year. Survival depends on more than avoiding smoking
Chronic obstructive pulmonary disease, or COPD, caused 141,733 deaths in the United States in 2023—the latest data that has ...
Hosted on MSN
Mumbai pulmonologist shares 9 tips to prevent COPD, world's 4th leading cause of death, amid rising pollution
World Health Organisation's November 2024 report stated that chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death globally, causing around 3.5 million deaths across the ...
Nebulisers are often used reactively, meaning they are introduced when symptoms become difficult to control rather than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results